Lexicon Pharmaceuticals
LXRX
#8815
Rank
NZ$0.21 B
Marketcap
$0.60
Share price
-3.56%
Change (1 day)
-85.60%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2023 (TTM): -$1.11

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$1.17. In 2022 the company made an earnings per share (EPS) of -$1.05 an increase over its 2021 EPS that were of -$1.05.

EPS history for Lexicon Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.115.95%
2022-$1.05-0%
2021-$1.0510.91%
2020-$0.95-145.08%
2019$2.10-206.09%
2018-$1.98-5.74%
2017-$2.10-10.95%
2016-$2.362640%
2015-$0.08605-96.34%
2014-$2.35-2.53%
2013-$2.41-9.09%
2012-$2.65-37.14%
2011-$4.220%
2010-$4.22-39.66%
2009-$6.993.57%
2008-$6.75-8.2%
2007-$7.35-24.69%
2006-$9.7642.11%
2005-$6.87-22.97%
2004-$8.91-35.09%
2003-$13.73-0%
2002-$13.7362.86%
2001-$8.43-19.54%
2000-$10.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$9.71 729.41%๐Ÿ‡บ๐Ÿ‡ธ USA
$64.29-5,594.12%๐Ÿ‡บ๐Ÿ‡ธ USA
-$17.62 1,405.88%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.34-214.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$26.40-2,355.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.85 314.71%๐Ÿ‡บ๐Ÿ‡ธ USA
-$45.79 3,813.24%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.70-330.88%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.29 10.29%๐Ÿ‡บ๐Ÿ‡ธ USA